FK 506 FOR LIVER, KIDNEY, AND PANCREAS TRANSPLANTATION
- 1 October 1989
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 334 (8670), 1000-1004
- https://doi.org/10.1016/s0140-6736(89)91014-3
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Renal transplantation in baboons under FK 506.1989
- EFFECTS OF COMBINATION TREATMENT WITH FK506 AND CYCLOSPORINE ON SURVIVAL TIME AND VASCULAR CHANGES IN RENAL-ALLOGRAFT-RECIPIENT DOGSTransplantation, 1989
- Immunosuppression of canine, monkey, and baboon allografts by FK 506: with special reference to synergism with other drugs and to tolerance induction.1988
- A highly sensitive method to assay FK-506 levels in plasma.1987
- Canine kidney transplantation with FK-506 alone or in combination with cyclosporine and steroids.1987
- Heterotopic heart transplantation in the rat receiving FK-506 alone or with cyclosporine.1987
- Orthotopic liver transplantation in dogs receiving FK-506.1987
- Effect of a new immunosuppressive agent, FK 506, on heterotopic cardiac allotransplantation in the rat.1987
- Pancreaticoduodenal transplantation in humans.1984
- CYCLOSPORIN A INITIALLY AS THE ONLY IMMUNOSUPPRESSANT IN 34 RECIPIENTS OF CADAVERIC ORGANS: 32 KIDNEYS, 2 PANCREASES, AND 2 LIVERSThe Lancet, 1979